Tarakji K - Search Results

1

Initial Experience With Non-Vitamin K Antagonist Oral Anticoagulants for Short-Term Anticoagulation After Left Atrial Appendage Closure Device.

Barakat AF, Wazni OM, Saliba WI, Saqi B, Abdur Rehman K, Tarakji K, Bassiouny M, Kanj M, Lindsay BD, Hussein AA. Barakat AF, et al. Among authors: tarakji k. JACC Clin Electrophysiol. 2017 Dec 11;3(12):1472-1473. doi: 10.1016/j.jacep.2017.02.013. Epub 2017 Nov 3. JACC Clin Electrophysiol. 2017. PMID: 29759681 Free article. No abstract available.

2

Experience with the hansen robotic system for atrial fibrillation ablation--lessons learned and techniques modified: Hansen in the real world.

Wazni OM, Barrett C, Martin DO, Shaheen M, Tarakji K, Baranowski B, Hussein A, Callahan T, Dresing T, Bhargava M, Kanj M, Tchou P, Natale A, Saliba W. Wazni OM, et al. Among authors: tarakji k. J Cardiovasc Electrophysiol. 2009 Nov;20(11):1193-6. doi: 10.1111/j.1540-8167.2009.01539.x. Epub 2009 Jun 30. J Cardiovasc Electrophysiol. 2009. PMID: 19572952 Clinical Trial.

3

Cardiac venous left ventricular lead removal and reimplantation following device infection: a large single-center experience.

Rickard J, Tarakji K, Cronin E, Brunner MP, Jackson G, Baranowski B, Borek PP, Martin DO, Wazni O, Wilkoff BL. Rickard J, et al. Among authors: tarakji k. J Cardiovasc Electrophysiol. 2012 Nov;23(11):1213-6. doi: 10.1111/j.1540-8167.2012.02392.x. Epub 2012 Aug 1. J Cardiovasc Electrophysiol. 2012. PMID: 22862738

4

Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.

Brunner MP, Cronin EM, Jacob J, Duarte VE, Tarakji KG, Martin DO, Callahan T, Borek PP, Cantillon DJ, Niebauer MJ, Saliba WI, Kanj M, Wazni O, Baranowski B, Wilkoff BL. Brunner MP, et al. Heart Rhythm. 2013 Oct;10(10):1444-50. doi: 10.1016/j.hrthm.2013.06.021. Epub 2013 Jun 28. Heart Rhythm. 2013. PMID: 23816440

5

Outcomes of patients requiring emergent surgical or endovascular intervention for catastrophic complications during transvenous lead extraction.

Brunner MP, Cronin EM, Wazni O, Baranowski B, Saliba WI, Sabik JF, Lindsay BD, Wilkoff BL, Tarakji KG. Brunner MP, et al. Heart Rhythm. 2014 Mar;11(3):419-25. doi: 10.1016/j.hrthm.2013.12.004. Epub 2013 Dec 4. Heart Rhythm. 2014. PMID: 24315967

6

Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions.

Brunner MP, Cronin EM, Duarte VE, Yu C, Tarakji KG, Martin DO, Callahan T, Cantillon DJ, Niebauer MJ, Saliba WI, Kanj M, Wazni O, Baranowski B, Wilkoff BL. Brunner MP, et al. Heart Rhythm. 2014 May;11(5):799-805. doi: 10.1016/j.hrthm.2014.01.016. Epub 2014 Jan 17. Heart Rhythm. 2014. PMID: 24444444

7

Outcomes after endocarditis or device infection in patients with left ventricular epicardial leads versus coronary sinus leads.

Karim S, Hussein A, Batal O, Karim MM, Tarakji K, Saliba W, Martin D, Wazni O, Kanj M, Wilkoff BL, Callahan T. Karim S, et al. Among authors: tarakji k. J Interv Card Electrophysiol. 2014 Apr;39(3):267-71. doi: 10.1007/s10840-014-9880-4. Epub 2014 Feb 23. J Interv Card Electrophysiol. 2014. PMID: 24562754

8

Survival of patients with biventricular devices after device infection, extraction, and reimplantation.

Rickard J, Tarakji K, Cheng A, Spragg D, Cantillon DJ, Martin DO, Baranowski B, Gordon SM, Tang WH, Kanj M, Wazni O, Wilkoff BL. Rickard J, et al. Among authors: tarakji k. JACC Heart Fail. 2013 Dec;1(6):508-13. doi: 10.1016/j.jchf.2013.05.009. Epub 2013 Dec 2. JACC Heart Fail. 2013. PMID: 24622003 Free article.

9

Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival.

Tarakji KG, Wazni OM, Harb S, Hsu A, Saliba W, Wilkoff BL. Tarakji KG, et al. Europace. 2014 Oct;16(10):1490-5. doi: 10.1093/europace/euu147. Epub 2014 Aug 2. Europace. 2014. PMID: 25087154

10

The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection.

Qintar M, Zardkoohi O, Hammadah M, Hsu A, Wazni O, Wilkoff BL, Tarakji KG. Qintar M, et al. Pacing Clin Electrophysiol. 2015 Feb;38(2):240-6. doi: 10.1111/pace.12514. Epub 2014 Sep 16. Pacing Clin Electrophysiol. 2015. PMID: 25224666

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page